CryoLife gets $99,000 research grant:
This article was originally published in Clinica
Executive Summary
CryoLife (US) has been awarded a $99,000 Phase I innovative research grant from the US NIH for its bioengineered human implantable heart valve. CryoLife will conduct studies using a porcine heart valve collagen matrix that can be "seeded" with human cells with the goal of creating a non-immunogenic heart valve for application in human replacement surgery. CryoLife has received four previous NIH grants since 1991, totalling $284,000 in development funding.